-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
RegMed XB CEO Bernard Mulder had the honor of meeting His Majesty King Willem-Alexander
On May 22, our General Director Bernard Mulder had the honor of joining His Majesty King Willem-Alexander of the Kingdom of the Netherlands, Prof. Yoshiki Sawa, Chairman of the Organization for Advanced Healthcare Innovation (Nakanoshima Qross), and H.E. Ms. Reinette Klever, Minister for Foreign Trade and Development Cooperation of the Netherlands.
read more
A Major Advancement for RegMed XB’s Diabetes Moonshot
As part of RegMed XB’s diabetes moonshot, researchers at the Leiden University Medical Center (LUMC) have developed a method to enhance the purity of insulin-producing islets, grown from stem cells in the laboratory. While originally aimed at diabetes, this technique has broader implications and could be applied to various stem cell-based therapies.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-
